Skip to main content

Table 4 Ranking probability of the efficiency of different treatments

From: Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis

  

Glyburide

Metformin

Insulin

  

Worst Best

Worst Best

Worst Best

  

Rank1

Rank2

Rank3

Rank1

Rank2

Rank3

Rank1

Rank2

Rank3

Glycemic control

FBG

0.34

0.44

0.22

0.62

0.33

0.05

0.04

0.23

0.73

2HPG

0.79

0.18

0.04

0.05

0.23

0.72

0.17

0.59

0.24

HbA1c

0.57

0.13

0.30

0.16

0.36

0.48

0.27

0.51

0.21

Neonatal outcomes

Anomaly

0.78

0.10

0.12

0.11

0.31

0.58

0.11

0.59

0.30

Hyperbiliru

0.86

0.10

0.04

0.03

0.29

0.68

0.11

0.61

0.28

LGA

0.94

0.05

0.01

0.01

0.19

0.80

0.05

0.76

0.19

Macrosomia

0.96

0.04

0.00

0.00

0.05

0.95

0.04

0.91

0.05

NICU admission

0.24

0.31

0.45

0.08

0.41

0.51

0.67

0.28

0.04

Neonatal hypoglycemia

0.94

0.05

0.00

0.00

0.04

0.95

0.05

0.90

0.04

Obstetric trauma

0.38

0.24

0.38

0.25

0.32

0.44

0.37

0.44

0.19

Perinatal death

0.59

0.27

0.14

0.11

0.24

0.66

0.31

0.49

0.20

Preterm birth

0.35

0.35

0.30

0.58

0.35

0.07

0.07

0.30

0.63

RDS

0.26

0.23

0.50

0.28

0.37

0.35

0.46

0.39

0.15

SGA

0.42

0.11

0.47

0.48

0.39

0.12

0.10

0.50

0.41

Birth weight

0.91

0.09

0.00

0.00

0.01

0.99

0.09

0.90

0.01

Preeclampsia

0.60

0.29

0.11

0.01

0.12

0.87

0.39

0.59

0.02

  1. LGA large-for-gestational age, SGA small-for-gestational age, RDS respiratory distress syndrome, NICU neonatal intensive care unit
  2. The probability (based on Bayesian analysis) of treatment being the worst (rank 1) or the best (rank 3). Bold indicates the probability of different treatment that are most likely to be ranked